Expression of MAGE-A1 and Its Clinical Signficance in Hepatocellular Carcinoma

XIAO Gang,ZHANG Wen-min,ZHANG Meng,XIE Dan,GUO Ai-lin,Wen Jian-ming

DOI: https://doi.org/10.3969/j.issn.1001-7399.2005.03.020

2005-01-01

Abstract:Purpose To investigate the expression of melanoma antigen-A1(MAGE-A1) gene in hepatocellular carcinomas and study the relationship between the expression of MAGE-A1 genes and the clinic pathological characterizations of patients with hepatocellular carcinomas (HCC). Methods The expressions of MAGE-A1 gene in 31 samples of hepatocellular carcinomas and corresponding adjacent noncancerous tissues were detected by reverse transcription-polymerase chain reaction(RT-PCR). MAGE-A1 antigen was detected using immunohistochemistry in 178 cases hepatocellular carcinomas and corresponding adjacent noncancerous tissues by tissue microarray technique. Results In the 31 hepatocellular carcinomas studied,MAGE-A1 mRNA was detected in 21 cases (67.74%). None of the corresponding adjacent noncancerous tissues expressed MAGE-A1 mRNA. In the 178 hepatocellular carcinomas studied,MAGE-A1 antigen was detected in 95 cases (53.37%). None of the corresponding adjacent noncancerous tissues expressed MAGE-A1 antigen. Conclusions MAGE-A1 gene is expressed in a high percentage of HCC,but it is unrelated to the clinic pathological characterizations of patients with HCC.